Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

from

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.

Subscribe to the Merantix Momentum Newsletter now.

The latest industry news, interviews, technologies and resources.

Clyravision: An entire forensics team in one system

Clyravision: The intelligent forensics system that not only recognizes manipulated images, but also explains exactly how and why they were altered - for more transparency and trust in the digital world.

From data chaos to breakthroughs

An expert interview with Dr. Stephan Hegge, VP of Corporate Strategy at HotSpot Therapeutics and Dr. Thomas Wollmann, CTO at Merantix Momentum

Article

AI as the key to administrative modernization: A practical step-by-step model for public administration

A practical step-by-step model explains how AI is becoming the central driver for efficiency, cultural change and the ability to act in administration.

Article

AI Readiness in the Industrial Sector - Do's and Don'ts

To our first edition of "The AI Interview" series on AI Readiness in the Industrial Sector.

Article

Why compliance officers can no longer afford to ignore AI

Compliance teams in Switzerland are faced with a flood of regulations. Find out how AI is easing the burden on banks, insurance companies and law firms - and making compliance smarter.

Data-driven to the drug of tomorrow

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.